Sodium arsenite suppresses human papillomavirus-16 E6 gene and enhances apoptosis in E6-transfected human lymphoblastoid cells

Journal of Cellular Biochemistry

Volumn 84, Issue 3, 2002, Pages 615-624

  Chou, Ruey Hwang ^a   Huang, Haimei ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; E6; Human papillomavirus; P53; Sodium arsenite

Indexed keywords

ARSENITE SODIUM; CASPASE 3; MESSENGER RNA; PROTEIN MDM2; PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL IMMORTALIZATION; CELL TRANSFORMATION; CELL VIABILITY; CONTROLLED STUDY; DNA DETERMINATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; VIRUS CARCINOGENESIS; VIRUS GENE; WART VIRUS; X IRRADIATION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRUS;

EID: 0035700688     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10055     Document Type: Article

References (43)

1. Introduction: The history of arsenic trioxide in cancer therapy
2. Use of arsenic trioxide (As203) in the treatment of acute promyelocytic leukemia (APL): I. As203 exerts dose-dependent dual effects on APL cells
3. Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis
4. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation
5. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system
6. Transfer of arsenite from glutathione to dithiols: A model of interaction
7. p53 mutations are rare events in recurrent cervical cancer
8. Arsenic compounds induce cytotoxicity and apoptosis in cisplatin-sensitive and -resistant gynecological cancer cell lines
9. Realtime monitoring and verification of in vivo high dose rate brachytherapy using a pinhole camera
10. p53-degradation by HPV-16 E6 preferentially affects the removal of cyclobutane pyrimidine dimers from non-transcribed strand and sensitizes mammary epithelial cells to UV-irradiation
11. Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors
12. Arsenic induces overexpression of growth factors in human keratinocytes
13. Does radiosterilization of the vagina occur through therapeutic radiation dosages?
14. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways
15. Radiation therapy in pregnancy: Risk calculation and risk minimization
16. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents
17. Activation of p53 in cervical carcinoma cells by small molecules
18. Glutathione as a cellular defence against arsenite toxicity in cultured Chinese hamster ovary cells
19. Abrogation of p53 function by transfection of HPV16 E6 gene does not enhance resistance of human tumour cells to ionizing radiation
20. Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of p53 and activation of caspase-3
21. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway
22. Inhibition of NF-kappa B activation by arsenite through reaction with a critical cysteine in the activation loop of Ikappa B kinase
23. MDM2 protein confers the resistance of a human glioblastoma cell line to cisplatin-induced apoptosis
24. 3) in the orthotopic metastasis model of androgen-independent prostate cancer
25. Sensitivity of myelomonocytic leukemia cells to arsenite-induced cell cycle disruption, apoptosis, and enhanced differentiation is dependent on the inter-relationship between arsenic concentration, duration of treatment, and cell cycle phase
26. Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products
27. Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth
28. Dosimetry of ionizing radiation used in the treatment of cervical and uterine cancer. Thermoluminescence determination of the dose at the rectum
29. The papillomavirus E6 proteins
30. Induction of p53 protein expression by sodium arsenite
31. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
32. Human papillomavirus type 16 DNA sequence
33. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients
34. Effects of human papillomavirus type 18-specific antisense oligonucleotides on the transformed phenotype of human carcinoma cell lines
35. The role of the E6-p53 interaction in the molecular pathogenesis of HPV
36. Locoregional intra-arterial chemotherapy combined with radiotherapy in cervical carcinoma
37. Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis
38. Arsenite induces apoptosis in Chinese hamster ovary cells by generation of reactive oxygen species
39. History of the development of arsenic derivatives in cancer therapy
40. The human papilloma virus 16E6 gene sensitizes human mammary epithelial cells to apoptosis induced by DNA damage
41. Abrogation of p53 function by HPV16 E6 gene dalays apoptosis and enhances mutagenesis but does not alter radiosensitivity in TK6 human lymphoblast cells
42. p53 is involved in but not required for ionizing radiation-induced caspase-3 activation and apoptosis in human lymphoblast cell lines
43. Papillomavirus infections - A major cause of human cancers